Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Low prevalence of most frequent pathogenic variants of six PARK genes in sporadic Parkinson's disease.

García S, López-Hernández LB, Suarez-Cuenca JA, Solano-Rojas M, Gallegos-Arreola MP, Gama-Moreno O, Valdez-Anguiano P, Canto P, Dávila-Maldonado L, Cuevas-García CF, Coral-Vázquez RM.

Folia Neuropathol. 2014;52(1):22-9.

2.

Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.

Yonova-Doing E, Atadzhanov M, Quadri M, Kelly P, Shawa N, Musonda ST, Simons EJ, Breedveld GJ, Oostra BA, Bonifati V.

Parkinsonism Relat Disord. 2012 Jun;18(5):567-71. doi: 10.1016/j.parkreldis.2012.02.018. Epub 2012 Mar 24.

PMID:
22445250
3.

Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease.

Choi JM, Woo MS, Ma HI, Kang SY, Sung YH, Yong SW, Chung SJ, Kim JS, Shin HW, Lyoo CH, Lee PH, Baik JS, Kim SJ, Park MY, Sohn YH, Kim JH, Kim JW, Lee MS, Lee MC, Kim DH, Kim YJ.

Neurogenetics. 2008 Oct;9(4):263-9. doi: 10.1007/s10048-008-0138-0. Epub 2008 Aug 15.

PMID:
18704525
4.

Analysis of the genetic variability in Parkinson's disease from Southern Spain.

Bandrés-Ciga S, Mencacci NE, Durán R, Barrero FJ, Escamilla-Sevilla F, Morgan S, Hehir J, Vives F, Hardy J, Pittman AM.

Neurobiol Aging. 2016 Jan;37:210.e1-210.e5. doi: 10.1016/j.neurobiolaging.2015.09.020. Epub 2015 Oct 8.

PMID:
26518746
5.

Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.

Zhang L, Quadri M, Guedes LC, Coelho M, Valadas A, Mestre T, Lobo PP, Rosa MM, Simons E, Oostra BA, Ferreira JJ, Bonifati V.

Parkinsonism Relat Disord. 2013 Oct;19(10):897-900. doi: 10.1016/j.parkreldis.2013.05.003. Epub 2013 May 28.

PMID:
23726462
6.

Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.

Benitez BA, Davis AA, Jin SC, Ibanez L, Ortega-Cubero S, Pastor P, Choi J, Cooper B, Perlmutter JS, Cruchaga C.

Mol Neurodegener. 2016 Apr 19;11:29. doi: 10.1186/s13024-016-0097-0.

7.

Genetic mutations in early-onset Parkinson's disease Mexican patients: molecular testing implications.

Monroy-Jaramillo N, Guerrero-Camacho JL, Rodríguez-Violante M, Boll-Woehrlen MC, Yescas-Gómez P, Alonso-Vilatela ME, López-López M.

Am J Med Genet B Neuropsychiatr Genet. 2014 Apr;165B(3):235-44. doi: 10.1002/ajmg.b.32228. Epub 2014 Feb 23.

PMID:
24677602
8.

Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.

Kilarski LL, Pearson JP, Newsway V, Majounie E, Knipe MD, Misbahuddin A, Chinnery PF, Burn DJ, Clarke CE, Marion MH, Lewthwaite AJ, Nicholl DJ, Wood NW, Morrison KE, Williams-Gray CH, Evans JR, Sawcer SJ, Barker RA, Wickremaratchi MM, Ben-Shlomo Y, Williams NM, Morris HR.

Mov Disord. 2012 Oct;27(12):1522-9. doi: 10.1002/mds.25132. Epub 2012 Sep 6. Review.

PMID:
22956510
9.

Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations.

Camargos ST, Dornas LO, Momeni P, Lees A, Hardy J, Singleton A, Cardoso F.

Mov Disord. 2009 Apr 15;24(5):662-6. doi: 10.1002/mds.22365.

10.

Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease.

Macedo MG, Verbaan D, Fang Y, van Rooden SM, Visser M, Anar B, Uras A, Groen JL, Rizzu P, van Hilten JJ, Heutink P.

Mov Disord. 2009 Jan 30;24(2):196-203. doi: 10.1002/mds.22287.

PMID:
18973254
11.

Analysis of Leucine-rich repeat kinase 2 (LRRK2) and Parkinson protein 2 (parkin, PARK2) genes mutations in Slovak Parkinson disease patients.

Bognar C, Baldovic M, Benetin J, Kadasi L, Zatkova A.

Gen Physiol Biophys. 2013 Mar;32(1):55-66. doi: 10.4149/gpb2013006.

PMID:
23531835
12.
13.

A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan.

Di Fonzo A, Wu-Chou YH, Lu CS, van Doeselaar M, Simons EJ, Rohé CF, Chang HC, Chen RS, Weng YH, Vanacore N, Breedveld GJ, Oostra BA, Bonifati V.

Neurogenetics. 2006 Jul;7(3):133-8. Epub 2006 Apr 22.

PMID:
16633828
14.

Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia.

Mellick GD, Siebert GA, Funayama M, Buchanan DD, Li Y, Imamichi Y, Yoshino H, Silburn PA, Hattori N.

Parkinsonism Relat Disord. 2009 Feb;15(2):105-9. doi: 10.1016/j.parkreldis.2007.11.016. Epub 2008 May 19.

PMID:
18486522
15.

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.

Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, Bressman S, Brice A, Aasly J, Zabetian CP, Goldwurm S, Ferreira JJ, Tolosa E, Kay DM, Klein C, Williams DR, Marras C, Lang AE, Wszolek ZK, Berciano J, Schapira AH, Lynch T, Bhatia KP, Gasser T, Lees AJ, Wood NW; International LRRK2 Consortium.

Lancet Neurol. 2008 Jul;7(7):583-90. doi: 10.1016/S1474-4422(08)70117-0. Epub 2008 Jun 6.

16.

A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.

Illarioshkin SN, Shadrina MI, Slominsky PA, Bespalova EV, Zagorovskaya TB, Bagyeva GKh, Markova ED, Limborska SA, Ivanova-Smolenskaya IA.

Eur J Neurol. 2007 Apr;14(4):413-7.

PMID:
17388990
17.

Common variants of LRRK2 are not associated with sporadic Parkinson's disease.

Biskup S, Mueller JC, Sharma M, Lichtner P, Zimprich A, Berg D, Wüllner U, Illig T, Meitinger T, Gasser T.

Ann Neurol. 2005 Dec;58(6):905-8.

PMID:
16254973
18.

Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease.

Yescas P, López M, Monroy N, Boll MC, Rodríguez-Violante M, Rodríguez U, Ochoa A, Alonso ME.

Neurosci Lett. 2010 Nov 19;485(2):79-82. doi: 10.1016/j.neulet.2010.08.029. Epub 2010 Aug 18.

PMID:
20727385
19.

Genetic and environmental findings in early-onset Parkinson's disease Brazilian patients.

Aguiar Pde C, Lessa PS, Godeiro C Jr, Barsottini O, Felício AC, Borges V, Silva SM, Saba RA, Ferraz HB, Moreira-Filho CA, Andrade LA.

Mov Disord. 2008 Jul 15;23(9):1228-33. doi: 10.1002/mds.22032.

PMID:
18464276
20.

The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease.

Li C, Ting Z, Qin X, Ying W, Li B, Guo Qiang L, Jian Fang M, Jing Z, Jian Qing D, Sheng Di C.

Mov Disord. 2007 Dec;22(16):2439-43.

PMID:
17960808

Supplemental Content

Support Center